|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| End-Stage Renal Disease | |||||
| Dialysis | |||||
| Hemodialysis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Kidney Diseases | |||||
| Kidney Failure, Chronic | |||||
| 3 | More general conditions related to this trial | ||||
| Kidney Failure | |||||
| Renal Insufficiency | |||||
| Renal Insufficiency, Chronic | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| N-acetylcysteine | |||||
| placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Acetylcysteine | |||||
| N-monoacetylcystine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antidotes | |||||
| Antioxidants | |||||
| Antiviral Agents | |||||
| Expectorants | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||